Cargando…
Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) patients represent a vulnerable population that may be susceptible to more severe COVID-19. Moreover, not only the underlying NAFLD may influence the progression of COVID-19, but the COVID-19 may affect the clinical course of NAFLD as well. Howev...
Autores principales: | Singh, Ambrish, Hussain, Salman, Antony, Benny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011308/ https://www.ncbi.nlm.nih.gov/pubmed/33862417 http://dx.doi.org/10.1016/j.dsx.2021.03.019 |
Ejemplares similares
-
Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
por: Hussain, Salman, et al.
Publicado: (2021) -
Association of Acute Kidney Injury with the Risk of Dementia: A Meta-Analysis
por: Hussain, Salman, et al.
Publicado: (2021) -
Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
por: Hussain, Salman, et al.
Publicado: (2022) -
Efficacy and safety of colchicine for the treatment of osteoarthritis: a systematic review and meta-analysis of intervention trials
por: Singh, Ambrish, et al.
Publicado: (2022) -
Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)